You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股》恆瑞醫藥(01276.HK)H股上市翌日回吐近4%
有「藥中茅台」之稱、上周五(23日)H股上市的內地龍頭醫藥股恆瑞醫藥(01276.HK)今早(26日)低開1.6%後,早段跌幅擴大,最低見52.9元。現報53元,跌3.9%,成交812.65萬股,涉資4.37億元。 該股H股上周五以招股價範圍上限44.05元掛牌,全日收報55.15元,高上市價25.2%。集資淨額97.47億元。其七名基石投資者包括GIC、Invesco Advisers、UBS AM Singapore、Cordial Solar、Hillhouse、Millennium及Oaktree,合共認購5.33億美元股份。 花旗5月初曾發表報告,料恆瑞醫藥2024年至2027年收入複合增長率為21%,總藥品銷售額複合增長率為22%,料創新藥業務收入複合增長率35%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account